What did GE HealthCare pay for Intelerad?

GE HealthCare acquired Intelerad for $2.30B in 2025 (28.4x EBITDA), equivalent to 8.50x revenue. Target revenue was approximately $270.0M. Target EBITDA was approximately $81.0M.

What does Intelerad do?

Intelerad is a healthcare it business.

What multiple did GE HealthCare pay for Intelerad?

28.4x EBITDA and 8.50x revenue, based on disclosed deal value of $2.30B and disclosed financials.

M&A TRANSACTION · 2025

Intelerad acquired by GE HealthCare

$2.30B· 28.4x EBITDA· 8.50x revenue

Target

Intelerad

Acquirer

GE HealthCare

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$270.0M

EBITDA

$81.0M

Deal Value

$2.30B

EV/EBITDA

28.4x

Context

This $2.30B acquisition of Intelerad by GE HealthCare sits in the healthcare it sub-vertical. The 28.4x EBITDA multiple paid in 2025 can be compared against the population median for healthcare it transactions of similar size on our Healthcare It valuation hub. GE HealthCare is acquiring as a strategic buyer; see how strategic acquirers typically price healthcare it businesses on our Healthcare It strategic buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own healthcare it

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Intelerad acquisition.

Citation: ExitValue.ai. (2025). Intelerad acquired by GE HealthCare. https://exitvalue.ai/deals/intelerad-acquired-by-ge-healthcare-hc-2025-0003